High Tower Advisors, LLC Amicus Therapeutics, Inc. Transaction History

High Tower Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$10.96 - $14.4 $242,446 - $318,542	-22,121 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$10.04 - $13.92 $222,094 - $307,924	22,121 New	22,121 $304,000
Q4 2017 Feb 14, 2018	SELL	$12.51 - $16.24 $351,068 - $455,743	-28,063 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$11.74 - $15.78 $191,385 - $257,245	-16,302 Reduced 36.75%	28,063 $421,000
Q2 2017 Aug 14, 2017	BUY	N/A	44,365	44,365 $441,000

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.